← All organizations
Axovant Sciences Inc
For profitWebsite ↗
Also known as: Axovant Sciences | Axovant Sciences, Inc. | Axovant Sciences, Inc., Clinical Research | Axovant Sciences Inc., Senior Vice President, Clinical Research | Axovant Sciences, Inc., Senior VP Clinical Research | Axovant Sciences, Inc., Vice President, Clinical Research | Axovant Sciences Ltd. | Sio Gene Therapies
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2015Last known activity
Dec 31, 2020
Defunct as of Dec 31, 2025
Timeline
2010s
- Jan 1, 2014
Axovant Sciences Inc— Founded
2020s
- Dec 31, 2025
Axovant Sciences Inc— Defunct
Drugs by trial phase (5 distinct, 11 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT04669535Study directorPhase 1Dec 31, 2020
- NCT04669535Lead sponsorPhase 1Dec 31, 2020
- NCT03952637CollaboratorPhase 1/Phase 2Jul 5, 2019
- NCT03720418Study directorPhase 1/Phase 2Oct 17, 2018
- NCT03720418Lead sponsorPhase 1/Phase 2Oct 17, 2018
- NCT02910102Lead sponsorPhase 2Oct 1, 2016
- NCT02928445Study directorPhase 2/Phase 3Oct 1, 2016
- NCT02928445Lead sponsorPhase 2/Phase 3Oct 1, 2016
- NCT02910102Study chairPhase 2Oct 1, 2016
- NCT02871427Lead sponsorPhase 2Aug 1, 2016
- NCT02871427Study directorPhase 2Aug 1, 2016
- NCT02586909Lead sponsorPhase 3Apr 1, 2016
- NCT02586909Study directorPhase 3Apr 1, 2016
- NCT02708186Study directorPhase 2Mar 1, 2016
- NCT02708186Lead sponsorPhase 2Mar 1, 2016
Details
- Founded
- London, GB Jan 1, 2014
- Last known activity
- Dec 31, 2020